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Acute Disseminated Encephalomyelitis (ADEM) is a rare autoimmune demyelinating disorder of the central nervous system. Clinical manifestations include encephalopathy, motor
deficits, ataxia, and meningeal signs. In most cases, ADEM is preceded by either vaccination
or viral illness. Here, we present a case with neither of the two predisposing elements.
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Discussion

A 28-year-old Hispanic female presenting with substance use and suicidal ideation was
placed on an involuntary psychiatric hold, started on olanzapine and scheduled for a psychiatric facility transfer. The following day, she was noted to have neurological deficits when
ambulating. Computed tomography of the brain showed a right frontal lesion. Magnetic
resonance imaging of the brain was notable for multiple peripherally enhancing white matter lesions. Multiple sclerosis and other etiologies were ruled out through supporting tests
and lumbar puncture. ADEM was suspected, and the patient was treated with both a fiveday course of intravenous methylprednisolone as well as immune globulins. She continued
to have mild expressive aphasia after treatment; however, the majority of her symptoms
improved.

Conclusions

Diagnosis of ADEM versus multiple sclerosis can be difficult given there are no current diagnostic criteria for it in the adult population. In this case, we explain how we reached a diagnosis of ADEM and provide further discussion regarding the disease course and treatment.
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Introduction

Acute disseminated encephalomyelitis (ADEM)
is an uncommon autoimmune demyelinating
disorder of the central nervous system.1,2 It is
more common in the pediatric population but
can occur in adults.3 In most cases, ADEM is
preceded by an acute viral illness and in extremely rare cases by vaccination.4,5,6 Clinical
manifestations include encephalopathy, motor
deficits, ataxia and meningeal signs. The combination of these non-specific symptoms, its
low incidence and lack of universally accepted
diagnostic criteria make it challenging to diagnose. Here we present a case of ADEM with
no known prior vaccination or preceding acute

viral illness, and discuss how we reached the
diagnosis.

Case Report

A 28-year-old Hispanic female was brought
to the emergency department with a chief
complaint of suicidal ideation. The patient,
who lived by herself, was on the phone with
her mother, when she reported snorting an
unknown substance and verbalized suicidal
ideation. Her mother then called emergency
medical services, who transported the patient
to our facility. The patient had no previous history of mental illness but had a history of domestic abuse and two spontaneous abortions.
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Her family noted that she had been exhibiting
strange behavior for approximately one week.
The behavior was first observed when her
family was watching her play in a softball game.
The patient, who was an avid softball player
for the past fifteen years, did not know how
to run around the bases properly. The family
also stated that she was fired from her job two
days prior to presentation, and it is believed
this was due to odd behavior. Psychiatry was
consulted by the emergency room physician for
suicidal ideation. Urine drug screen was negative (Table 1). The initial examination revealed
the patient to be responding to internal stimuli
(talking to herself). She was placed on an involuntary psychiatric hold, started on olanzapine
and planned to be transferred to an inpatient
psychiatric facility.
The following day the patient was noted to
be swaying in bed and having ataxic gait while
walking with a nurse. A computed tomography
(CT) of the brain without contrast was obtained (Figure 1A) which was notable for a right
frontal lesion. The initial transfer to a psychiatric facility was cancelled, and the patient was
admitted to an intermediate care bed (IMC)
under the internal medicine service. Magnetic resonance imaging (MRI) of the brain with
contrast (Figure 2A) was obtained and revealed
multiple peripherally enhancing white matter
lesions in the deep cortical matter with sparing
of the corpus callosum. CT angiography of the
head and neck, MR angiography of the brain,
and MRI of the cervical spine and thoracic spine
were all negative.
A lumbar puncture was performed, yielding an
elevated cerebrospinal fluid (CSF) white blood
cell count of 0.045 x 103 µL (normal 0-0.005 µL)
with elevated lymphocytes (97%) and elevated myelin basic protein of 37.2 ng/mL (normal
0.0-1.2 ng/mL). Oligoclonal bands, JC virus and
toxoplasma antibody were negative. Further
lab testing was performed over the next few
days and was negative (Table 1), except for Borrelia burgdorferi IgG, Epstein Barr Virus PCR
and Varicella-Zoster Virus IgG.
The electroencephalogram while the patient
was awake showed a posterior dominant
background rhythm consisting of low to normal
amplitude (6-8 Hertz) theta slowing. Occasional sleep spindles were seen towards the end of
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Table 1. Negative and Normal Labs
Acetaminophen level
Ammonia level
Anti-neutrophil cytoplasmic antibodies (ANCA)
Anti-nuclear antibody (ANA)
Ceruloplasmin
Complement C3 and C4
Complete blood count (CBC)
Comprehensive metabolic panel (CMP)
Corticotropin
C-reactive protein (CRP)
Creatine kinase (CK)
Cryoglobulin
Cytomegalovirus IgG
Erythrocyte sedimentation rate (ESR)
Free T4
Haptoglobin
HCG
Hemoglobin A1C
Hepatitis A
Hepatitis B core
Hepatitis B surface
Hepatitis C
HIV-2 Ab
HIV screen
HSV 1 & 2 PCR
Lactic acid dehydrogenase (LDH)
Lipid panel
Lupus anticoagulant
Paraneoplastic antibody profile
Salicylate level
T-cell populations (CD3, CD4, CD8)
Thyroid-stimulating hormone (TSH)
Treponema pallidum antibody
Troponin
Urine drug screen
Urine analysis
VDRL
Vitamin B12 level
West Nile
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Figure 1.
A) Computed tomography (CT) of the brain without contrast showing a 2 x 1.9 x 1.7 cm low-density area in the right frontal lobe in the axial plane. Differential included encephalomalacia, subacute infarct or mass.
B) A repeat CT of brain without contrast 3 days after the first CT showing increasing hypo-density to the lesion, which is suggestive of a subacute phase.
the study. No electrographic seizures, focal/
lateralizing discharges, periodic discharges or
epileptiform activity was seen. The EEG was
consistent with mild background slowing,
which is commonly seen in cases of mild encephalopathy.
These overall findings were most characteristic of acute disseminated encephalomyelitis
(ADEM) although multiple sclerosis (MS) and
other pathology needed to be ruled out. After
reviewing the findings, ADEM best explained
the findings. Intravenous (IV) methylprednisolone at a dosage of 1 gram every 24 hours was
started. Over the next 48 hours the patient’s
mentation worsened, and she became increasingly aphasic with associated hypotension.
A repeat CT of the brain without contrast
(Figure 1B) showed increasing hypo-density
of the previous lesions, indicating a subacute
phase. Intravenous immunoglobulin (IVIG) was
then started in addition to the IV methylprednisolone. After 24 hours of IVIG the patient’s
mental status, including her aphasia began to
improve.
The patient received both a five-day course of
IV methylprednisolone and IVIG. The IV methylprednisolone was started on day 2 of admission
and the IVIG was started on day 5. Repeat MRI
of the brain with contrast post-IVIG (Figure
2B) still showed multiple white matter lesions with increasing surrounding edema, but
the enhancing components had resolved. The
patient’s mentation improved, and she was
speaking full sentences with mild expressive
aphasia. The patient was then discharged to a
skilled nursing and rehabilitation facility.

Discussion

The case demonstrates the importance of
conducting a thorough history and physical
exam, especially when determining whether a patient’s symptoms are the result of an
acute psychiatric illness versus an underlying
neurological disease. Initially, the patient was
thought to have an acute psychiatric illness.
However, the presence of a neurological abnormality on physical exam, noticed approximately
twelve hours after her presentation, ultimately resulted in the discovery of an underlying
neurological cause of the patient’s symptoms.
Although new-onset schizophrenia can commonly present in young females (20-30 years
old), there are several details within the history
and physical itself that make the psychiatric
illness less likely.7,8 The most important detail
is the fact that the patient had motor deficits
(i.e. not being able to run the bases at her softball game properly) and ataxic gait.9
The ramifications of misdiagnosis can be fatal,
as mortality rates in cases of ADEM have been
reported to be as high as 20-25%.10,11 ADEM also
has a hyperacute variant known as acute necrotizing hemorrhagic leukoencephalitis of Weston
Hurst. This variant is a fulminant syndrome
representing approximately 2% of ADEM cases
and is characterized by abrupt onset of seizures, neck stiffness and fever with the finding
of petechial hemorrhages on brain imaging.12, 13
Acute necrotizing hemorrhagic leukoencephalitis has more than a 50% mortality rate.14
Acute disseminated encephalomyelitis most
often occurs 2-4 weeks after exposure to a
viral illness or vaccination. Our patient did not
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Figure 2.
A) Magnetic resonance imaging (MRI) of the brain with contrast. Shown from left to right are
T2 weighted axial, sagittal and coronal planes showing innumerable peripherally enhancing white
matter lesions distributed throughout the periventricular, deep and juxtacortical white matter of
the supratentorial brain with sparing of the posterior fossa and corpus callosum.
B) Repeat MRI of the brain with contrast 8 days after the above MRI. Shown from left to right
are a T2 weighted image in the axial plane, a reformatted post-gadolinium BRAVO image in the
sagittal plane and a T2 weighted image in the coronal plane. The MRI is notable for a large number
of white matter lesions that persist and demonstrate a mild increase in surrounding edema. However, the enhancing components have resolved. Of note, the study was limited due to the motion
artifact.
receive any vaccinations within the past six
months; however, it is unconfirmed if she had
suffered a recent viral illness, as she lived alone
and was unable to give a history due to acute
encephalopathy. Serum testing for Epstein
Barr (EB) PCR, Varicella-Zoster IgG, and Borrelia burgdorferi IgG were positive. Positive EB
can be explained by the reactivation of the virus
post steroid treatment (transient viremia). The
patient did not have signs of lymphoproliferative disorders, chronic active Epstein Barr virus
infection or infectious mononucleosis.
There are currently no definitive diagnostic
criteria for ADEM in the adult population (only
suggested criteria); therefore, ADEM is considered a diagnosis of exclusion based on imaging
findings, symptoms, serum studies and cerebrospinal fluid analysis. MRI of the brain with
contrast is the study of choice as it provides
optimal visualization of demyelinating CNS
lesions and the soft tissue. Pathognomonic imaging findings on MRI for ADEM include lesions
that are large in size, with irregular borders
typically located in the white matter with spar80

ing of the corpus callosum (although lesions
can occur here).13 Spinal cord involvement with
ADEM is variable, with some sources reporting as low as a 30% occurrence to as high as
an 80% occurrence in adults.15,16 Cerebrospinal
fluid analysis in patients with ADEM typically
is absent for oligoclonal bands, whereas an elevated white blood cell count with a lymphocytic
pleocytosis and elevated protein level are more
common.6 Seze et al proposed that ADEM
could be diagnosed based on the presence of
2 of the following 3 criteria: (1) Clinical symptoms atypical for MS, including 1 or more of the
following: consciousness alteration, hypersomnia, seizures, cognitive impairment, hemiplegia,
tetraplegia, aphasia or bilateral optic neuritis;
(2) Absence of OCB (oligoclonal bands) in CSF;
and (3) Gray matter involvement (basal ganglia
or cortical lesions).17 Our patient met 2 of the 3
above criteria (atypical symptoms and absence
of OCB) which is compatible with a diagnosis
of ADEM.
Differentiation between ADEM and MS is difficult, as there can be an overlapping of symp-
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toms. In this case, the diagnosis of ADEM was
reached based on multiple factors, including
the absence of oligoclonal bands in the CSF,
the presence of acute encephalopathy, ataxic
gait, imaging findings including bilateral lesions
with variance in size and sparing of the corpus
callosum, as well as the absence of old demyelinating lesions on the brain MRI. Of note,
further imaging of the patient’s central nervous system, including MRI of the cervical and
thoracic spine, were negative for demyelinating
lesions.

We also cannot conclude if the patient’s symptoms were improved by glucocorticoids or
IVIG. The patient received two days of intravenous glucocorticoids with no improvement in
symptoms, and due to neurological worsening,
the decision was made to start IVIG prior to
completion of full steroid course. The patient’s
symptoms improved remarkably with this combined treatment. However, we cannot conclude
whether glucocorticoids or IVIG were more
effective.

Other neurological conditions such as anti-N-methyl-D-aspartic acid (NMDA) receptor
encephalitis may also be considered in a young
female patient. However, there were no clinical signs such as headache, fever or viral-like
processes to suggest this entity. The absence
of a Delta brush on the electroencephalogram
and the presence of multiple demyelinating
lesions on the brain MRI made this an unlikely diagnosis. MRI in patients with anti-NMDA
receptor encephalitis is typically normal or occasionally shows enhanced T2 FLAIR signaling
with non-specific white matter changes.16 CSF
protein elevation is also less common.18

Acute disseminated encephalomyelitis can be
difficult to diagnose, as the presentation of
symptoms can be similar to both other demyelinating diseases and psychiatric disorders.
After an extensive workup, we can conclude
that this patient’s symptoms, imaging findings,
and CSF testing are consistent with ADEM and
that glucocorticoids and IVIG are an effective
treatment.

Treatment for ADEM includes glucocorticoids,
IVIG and plasmapheresis. Intravenous methylprednisolone at a dosage of 1 gram every 24
hours for a course of 3 to 5 days is typically
recommended.2 IVIG and plasmapheresis are
treatment options if symptoms are refractory to glucocorticoids. Currently, there are no
randomized clinical trials for either of these
therapies, and the majority of data stems from
observational studies.19 In contrast to multiple
sclerosis, IVIG is not considered a standard of
treatment for acute episodes and has not been
shown to provide additional clinical benefit.20
Further treatment options for ADEM not used
in this case include plasmapheresis and cyclophosphamide. ADEM typically does not recur,
unlike MS; therefore, chronic immuno-suppressive therapy is not indicated.4

Limitations

In this case, an anti-glu N1 antibody which is
diagnostic for anti-NMDA receptor encephalitis
was ordered but never resulted. However, as
discussed previously, the MRI and EEG results
make this diagnosis less likely.

Conclusions
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